How Zovaglutide affects heart rhythm in healthy adults
Part of Hormones & metabolism clinical trials.
This study tests if a new medication called Zovaglutide affects the heart's electrical activity (QTc interval) in healthy adults. It helps ensure the drug is safe before moving to larger trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 45 years old.
- Your body mass index (BMI) must be between 24.0 and 35.0.
- Men must weigh more than 60 kg (about 132 lbs) and women more than 55 kg (about 121 lbs).
- You cannot have a history of heart rhythm problems, pancreatitis, certain thyroid cancers, or other major health conditions.
- You cannot be pregnant, breastfeeding, or have used weight-loss medications recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called Zovaglutide (ZT002) in people with different levels of kidney function, from normal to severely impaired. The goal is to see how the drug is processed by the body and how safe it is for people with kidney problems.
This study tests how a new diabetes medicine called ZT002 works in the body and whether it interacts safely with other common medications. Researchers will monitor healthy volunteers who are overweight to understand the medicine's safety and effectiveness.
This trial tests a new oral medication (GZC8072) in two groups: healthy people given a single dose, and people who are overweight or obese given multiple doses. The study aims to see if the drug is safe and how the body handles it, and may help with weight management.
This trial tests how a new injectable drug, GZR18, affects how fast your stomach empties and how it interacts with other medicines. It is for obese Chinese adults who want to join a research study.
This trial tests how a new oral medication affects the heart's electrical activity. It is for healthy volunteers aged 18 to 45 to help ensure the drug is safe before testing in patients.
This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.
Hear when a new Overweight, Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.